NATALIE O'ROURKE: Open Payments
NPI 1659034668 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 26 payments from 12 companies in 2025. Trend: 2023 $853 · 2024 $838 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $91 |
| Amgen Inc. | 4 | $73 |
| Novo Nordisk Inc | 3 | $56 |
| Biosense Webster, Inc. | 2 | $47 |
| Philips North America LLC | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| CVRx, Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: VERQUVO, REPATHA, Wegovy, CARTO 3, Barostim Neo System, MCOT, MITRACLIP, Kerendia.
Industry payments across FL — which companies pay providers there.
